F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Fibrosis

Page 1 of 4 ( 160 items )
<<
1
2
3
4
>>

1	Hepatoprotective effects of silybin in liver fibrosis 11/13/2025 6:51:09 AM \| Browse: 12 \| Download: 42
2	Immunoglobulin G4-related disease in the sigmoid colon in patient with severe colonic fibrosis and obstruction: A case report 10/25/2022 11:36:14 AM \| Browse: 568 \| Download: 1467
3	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 559 \| Download: 1236
4	Use of shear wave elastography for the diagnosis and follow-up of biliary atresia: A meta-analysis 8/26/2022 7:50:06 AM \| Browse: 502 \| Download: 1163
5	Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China 7/18/2022 9:47:46 AM \| Browse: 684 \| Download: 2487
6	Anabolic androgenic steroid-induced liver injury: An update 7/13/2022 7:30:59 AM \| Browse: 689 \| Download: 1331
7	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 589 \| Download: 1767
8	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 649 \| Download: 1223
9	Loss of LAT1 sex-dependently delays recovery after caerulein-induced acute pancreatitis 3/11/2022 9:47:59 AM \| Browse: 649 \| Download: 1550
10	Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars 2/25/2022 12:19:16 PM \| Browse: 675 \| Download: 1530
11	Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study 1/21/2022 8:16:14 AM \| Browse: 622 \| Download: 1622
12	Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? 12/27/2021 5:24:00 AM \| Browse: 558 \| Download: 1506
13	De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation 12/27/2021 5:24:00 AM \| Browse: 649 \| Download: 1353
14	Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model 12/17/2021 8:56:01 AM \| Browse: 743 \| Download: 2120
15	Application of adipose-derived stem cells in treating fibrosis 11/25/2021 8:31:20 AM \| Browse: 622 \| Download: 1272
16	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 621 \| Download: 1087
17	Artificial intelligence for hepatitis evaluation 9/9/2021 6:46:56 AM \| Browse: 797 \| Download: 1469
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 789 \| Download: 1352
19	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 751 \| Download: 1263
20	Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation 6/23/2021 1:49:40 AM \| Browse: 883 \| Download: 1639
21	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 858 \| Download: 1445
22	Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B 3/18/2021 8:34:30 AM \| Browse: 766 \| Download: 1578
23	Histopathology and predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy 1/29/2021 7:57:41 AM \| Browse: 809 \| Download: 2284
24	Autophagy in liver diseases 1/26/2021 4:22:54 PM \| Browse: 849 \| Download: 1563
25	Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells 11/24/2020 12:41:21 PM \| Browse: 858 \| Download: 2078
26	Efficacy and safety of anti-hepatic fibrosis drugs 11/6/2020 7:36:12 AM \| Browse: 942 \| Download: 2076
27	Advances in the treatment of nonalcoholic steatohepatitis 10/29/2020 5:34:30 AM \| Browse: 1090 \| Download: 2072
28	Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis 6/6/2020 2:43:56 PM \| Browse: 1146 \| Download: 2321
29	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 1021 \| Download: 1673
30	Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma 1/16/2020 7:58:40 AM \| Browse: 1053 \| Download: 1897
31	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 1307 \| Download: 1953
32	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source 9/7/2019 4:43:36 AM \| Browse: 1183 \| Download: 2648
33	Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis 8/21/2019 9:19:18 AM \| Browse: 1212 \| Download: 2312
34	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 986 \| Download: 1377
35	Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets 7/6/2019 6:23:58 AM \| Browse: 1416 \| Download: 2502
36	Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis 5/27/2019 8:24:36 AM \| Browse: 1070 \| Download: 2006
37	Effectiveness of venous thromboembolism prophylaxis in patients with liver disease 4/26/2019 3:40:00 AM \| Browse: 1132 \| Download: 2039
38	Repurposing drugs to target nonalcoholic steatohepatitis 4/18/2019 5:48:09 AM \| Browse: 1215 \| Download: 1974
39	Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication 3/27/2019 10:37:20 AM \| Browse: 1342 \| Download: 2648
40	Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus 3/20/2019 5:32:10 AM \| Browse: 1372 \| Download: 2673
41	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1350 \| Download: 2136
42	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1305 \| Download: 2001
43	Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression 1/26/2019 11:40:14 AM \| Browse: 1496 \| Download: 1885
44	Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study 1/26/2019 8:24:19 AM \| Browse: 1134 \| Download: 2110
45	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1450 \| Download: 2140
46	Role of cenicriviroc in the management of nonalcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1098 \| Download: 1690
47	Management of local recurrence after endoscopic resection of neoplastic colonic polyps 12/21/2018 6:09:14 AM \| Browse: 1207 \| Download: 1916
48	Liver as a target of human immunodeficiency virus infection 11/13/2018 8:04:45 AM \| Browse: 1318 \| Download: 1977
49	Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer 10/18/2018 10:13:24 AM \| Browse: 1221 \| Download: 1867
50	A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease 9/7/2018 9:21:44 AM \| Browse: 1233 \| Download: 2450

Page 1 of 4 ( 160 items )
<<
1
2
3
4
>>

1	Hepatoprotective effects of silybin in liver fibrosis 11/13/2025 6:51:09 AM \| Browse: 12 \| Download: 42
2	Immunoglobulin G4-related disease in the sigmoid colon in patient with severe colonic fibrosis and obstruction: A case report 10/25/2022 11:36:14 AM \| Browse: 568 \| Download: 1467
3	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 559 \| Download: 1236
4	Use of shear wave elastography for the diagnosis and follow-up of biliary atresia: A meta-analysis 8/26/2022 7:50:06 AM \| Browse: 502 \| Download: 1163
5	Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China 7/18/2022 9:47:46 AM \| Browse: 684 \| Download: 2487
6	Anabolic androgenic steroid-induced liver injury: An update 7/13/2022 7:30:59 AM \| Browse: 689 \| Download: 1331
7	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 589 \| Download: 1767
8	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 649 \| Download: 1223
9	Loss of LAT1 sex-dependently delays recovery after caerulein-induced acute pancreatitis 3/11/2022 9:47:59 AM \| Browse: 649 \| Download: 1550
10	Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars 2/25/2022 12:19:16 PM \| Browse: 675 \| Download: 1530
11	Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study 1/21/2022 8:16:14 AM \| Browse: 622 \| Download: 1622
12	Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? 12/27/2021 5:24:00 AM \| Browse: 558 \| Download: 1506
13	De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation 12/27/2021 5:24:00 AM \| Browse: 649 \| Download: 1353
14	Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model 12/17/2021 8:56:01 AM \| Browse: 743 \| Download: 2120
15	Application of adipose-derived stem cells in treating fibrosis 11/25/2021 8:31:20 AM \| Browse: 622 \| Download: 1272
16	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 621 \| Download: 1087
17	Artificial intelligence for hepatitis evaluation 9/9/2021 6:46:56 AM \| Browse: 797 \| Download: 1469
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 789 \| Download: 1352
19	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 751 \| Download: 1263
20	Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation 6/23/2021 1:49:40 AM \| Browse: 883 \| Download: 1639
21	Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand? 3/18/2021 10:54:40 AM \| Browse: 858 \| Download: 1445
22	Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B 3/18/2021 8:34:30 AM \| Browse: 766 \| Download: 1578
23	Histopathology and predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy 1/29/2021 7:57:41 AM \| Browse: 809 \| Download: 2284
24	Autophagy in liver diseases 1/26/2021 4:22:54 PM \| Browse: 849 \| Download: 1563
25	Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells 11/24/2020 12:41:21 PM \| Browse: 858 \| Download: 2078
26	Efficacy and safety of anti-hepatic fibrosis drugs 11/6/2020 7:36:12 AM \| Browse: 942 \| Download: 2076
27	Advances in the treatment of nonalcoholic steatohepatitis 10/29/2020 5:34:30 AM \| Browse: 1090 \| Download: 2072
28	Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis 6/6/2020 2:43:56 PM \| Browse: 1146 \| Download: 2321
29	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 1021 \| Download: 1673
30	Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma 1/16/2020 7:58:40 AM \| Browse: 1053 \| Download: 1897
31	Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C 1/13/2020 11:27:12 AM \| Browse: 1307 \| Download: 1953
32	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source 9/7/2019 4:43:36 AM \| Browse: 1183 \| Download: 2648
33	Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis 8/21/2019 9:19:18 AM \| Browse: 1212 \| Download: 2312
34	Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease 7/28/2019 10:51:57 AM \| Browse: 986 \| Download: 1377
35	Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets 7/6/2019 6:23:58 AM \| Browse: 1416 \| Download: 2502
36	Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis 5/27/2019 8:24:36 AM \| Browse: 1070 \| Download: 2006
37	Effectiveness of venous thromboembolism prophylaxis in patients with liver disease 4/26/2019 3:40:00 AM \| Browse: 1132 \| Download: 2039
38	Repurposing drugs to target nonalcoholic steatohepatitis 4/18/2019 5:48:09 AM \| Browse: 1215 \| Download: 1974
39	Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication 3/27/2019 10:37:20 AM \| Browse: 1342 \| Download: 2648
40	Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus 3/20/2019 5:32:10 AM \| Browse: 1372 \| Download: 2673
41	Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice 3/20/2019 5:32:10 AM \| Browse: 1350 \| Download: 2136
42	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1305 \| Download: 2001
43	Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression 1/26/2019 11:40:14 AM \| Browse: 1496 \| Download: 1885
44	Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study 1/26/2019 8:24:19 AM \| Browse: 1134 \| Download: 2110
45	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1450 \| Download: 2140
46	Role of cenicriviroc in the management of nonalcoholic fatty liver disease 12/27/2018 8:56:32 AM \| Browse: 1098 \| Download: 1690
47	Management of local recurrence after endoscopic resection of neoplastic colonic polyps 12/21/2018 6:09:14 AM \| Browse: 1207 \| Download: 1916
48	Liver as a target of human immunodeficiency virus infection 11/13/2018 8:04:45 AM \| Browse: 1318 \| Download: 1977
49	Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer 10/18/2018 10:13:24 AM \| Browse: 1221 \| Download: 1867
50	A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease 9/7/2018 9:21:44 AM \| Browse: 1233 \| Download: 2450